Developer docs
API playgroundTry for free, no card

Search company profiles

International Biophysics Corporation

Full company profile

uuid000xj8q

Namestring
International Biophysics Corporation
Legal namestring
International Biophysics Corporation
Company typeenum
Private
Founded yearint
1994
Descriptiontext

International Biophysics Corporation, doing business as Movair, is a privately held medical device company headquartered in Austin, Texas, focused on respiratory therapy hardware for patients with chronic respiratory conditions. The company was founded in 1994 (rebranded to Movair approximately 2021) and has been operating in the life-supporting respiratory therapy space for over 30 years. Its product portfolio comprises three core devices: the AffloVest, a portable mechanical insufflation-exsufflation therapy vest; the LUISA, a portable, compact home ventilator co-developed with Löwenstein Medical and authorized by the FDA under Emergency Use Authorization; and SimplyAir, a foam-free bi-level positive airway pressure device for non-invasive ventilation. The portfolio spans mechanical cough assistance through to non-invasive home ventilation, enabling chronic respiratory patients to receive targeted therapy in home and clinical settings.

The company's technology stack centers on purpose-built respiratory hardware with proprietary architectural features (AffloVest portable vest design, LUISA's TTV-VAP-AE ventilation mode, SimplyAir's foam-free bi-level construction) plus cloud-based remote monitoring via Löwenstein's Prisma Cloud platform, which gives physicians remote access to patient device data. Movair generates revenue primarily through hardware sales of durable medical equipment to patients and healthcare providers, supplemented by reimbursement support services that facilitate insurance, Medicare, and Medicaid claims. Distribution is exclusively domestic (United States), conducted through physician-prescribed, hospital and clinical channels under FDA regulatory oversight, with all devices requiring a physician order per U.S. federal law.

The go-to-market model is enterprise field sales through healthcare providers and clinical partnerships, with the company maintaining a certified customer repair portal and customer portal for ongoing patient support. The partnership with Löwenstein Medical is the most strategically significant external relationship, providing the ventilation technology underlying LUISA and the Prisma Cloud remote monitoring infrastructure. Leadership consists of founder and CEO Syed Shabbir Hussain Rizvi, with the broader management team not disclosed in available source material.

Short descriptiontext

International Biophysics Corporation (Movair) is an Austin-based medical device company that designs, sells, and supports FDA-regulated respiratory therapy hardware — the AffloVest, LUISA portable ventilator, and SimplyAir bi-level device — for patients with chronic respiratory conditions, distributed domestically through physician-prescribed clinical channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
respiratory medical devices, home ventilators, bi-level therapy devices, portable ventilators, mechanical insufflation devices
Industry3 codes
1Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
CodeHLAHAGACPrimaryYes
2Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters)
CodeHLAHAGAGPrimaryNo
3Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
CodeHLAKANAMPrimaryNo
NAICS code2 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Respiratory Medical Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of respiratory medical devices including AffloVest, LUISA ventilator, and SimplyAir Bi-Levels to patients and healthcare providers. Devices require physician prescription and are subject to FDA regulation.

movair.com
2Reimbursement Services
TypeManaged Services
Description

The company provides reimbursement support for SimplyAir and LUISA devices, indicating revenue recovery through healthcare insurance and Medicare/Medicaid channels typical for durable medical equipment.

movair.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

International Biophysics Corporation (doing business as Movair) designs, manufactures, and distributes FDA-regulated respiratory medical devices for patients with chronic respiratory conditions. Its product portfolio includes the AffloVest wearable respiratory therapy vest, the LUISA portable home ventilator (FDA EUA-authorized, co-developed with Löwenstein Medical), and the SimplyAir foam-free bi-level positive airway pressure device. The company sells through healthcare provider channels with physician prescription requirements and provides reimbursement support services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

International Biophysics Corporation (doing business as Movair) offers a unified portfolio of respiratory care medical devices. The product lineup includes the AffloVest (portable mechanical insufflation-exsufflation therapy vest), LUISA (a portable home ventilator developed with Löwenstein Medical, FDA EUA authorized), and SimplyAir (a FOAM FREE bi-level device). These products work together to provide comprehensive respiratory support across different therapy modalities—from mechanical cough assistance to non-invasive ventilation—enabling patients with chronic respiratory conditions to receive targeted treatment at home.

Product and service1 record
1AffloVest
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Löwenstein Medical co-developed the LUISA portable home ventilator with Movair. The LUISA represents a strategic collaboration combining Movair's respiratory therapy expertise with Löwenstein Medical's ventilation technology. The device has received FDA emergency use authorization.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global leader in CPAP, BiPAP, and home ventilation devices serving patients with sleep apnea and chronic respiratory conditions. Directly comparable to Movair's LUISA home ventilator and SimplyAir Bi-level offerings, with overlapping physician and DME channel.

TypeEmerging player
Description

China-based manufacturer of CPAP, BiPAP, and respiratory care devices expanding internationally. Competes in the same BiPAP and home ventilation categories as Movair's SimplyAir and LUISA, particularly in non-US markets.

TypeDirect peer
Description

Swiss manufacturer of mechanical ventilators for ICU, transport, and home use. Comparable to Movair in ventilation technology focus, with complementary ICU/home portfolio that may overlap with Movair's LUISA home ventilator.

TypeDirect peer
Description

Major manufacturer of CPAP, BiPAP, and home/hospital ventilators. Competes head-to-head with Movair's home ventilator and Bi-level portfolio across US hospital and DME channels.

TypeDirect peer
Description

German respiratory and ventilation device manufacturer and Movair's strategic co-development partner on LUISA. Operates in overlapping therapeutic categories including home ventilation and NIV, and is both a partner and direct competitive peer.

TypeRegional player
Description

US-based manufacturer of portable oxygen concentrators for chronic respiratory patients. Comparable home-channel respiratory therapy model but oxygen-focused; serves overlapping chronic respiratory patient segments.

TypeDirect peer
Description

US-based manufacturer and distributor of respiratory DME including CPAP, BiPAP, and oxygen therapy devices. Comparable channel strategy through DME providers and overlapping product categories with Movair.

TypeDirect peer
Description

US respiratory device company offering home and portable ventilators (VOCSN) plus sleep therapy devices. Directly comparable to Movair's multi-modality home respiratory portfolio and channel strategy.

TypeBroad incumbent
Description

New Zealand-based manufacturer of respiratory care products including humidification, NIV masks, and circuits. Adjacent to Movair's NIV and home respiratory therapy portfolio through hospital and home care channels.

TypeDirect peer
Description

Specialist in home mechanical ventilators and Bi-level PAP devices, headquartered in Europe with US distribution. Closely comparable to Movair's LUISA and SimplyAir product positioning for chronic respiratory patients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

International Biophysics Corporation

Respiratory Medical Devicesbiophysicscorp.com

International Biophysics Corporation (Movair) is an Austin-based medical device company that designs, sells, and supports FDA-regulated respiratory therapy hardware — the AffloVest, LUISA portable ventilator, and SimplyAir bi-level device — for patients with chronic respiratory conditions, distributed domestically through physician-prescribed clinical channels.

What International Biophysics Corporation does

International Biophysics Corporation, doing business as Movair, is a privately held medical device company headquartered in Austin, Texas, focused on respiratory therapy hardware for patients with chronic respiratory conditions. The company was founded in 1994 (rebranded to Movair approximately 2021) and has been operating in the life-supporting respiratory therapy space for over 30 years. Its product portfolio comprises three core devices: the AffloVest, a portable mechanical insufflation-exsufflation therapy vest; the LUISA, a portable, compact home ventilator co-developed with Löwenstein Medical and authorized by the FDA under Emergency Use Authorization; and SimplyAir, a foam-free bi-level positive airway pressure device for non-invasive ventilation. The portfolio spans mechanical cough assistance through to non-invasive home ventilation, enabling chronic respiratory patients to receive targeted therapy in home and clinical settings.

The company's technology stack centers on purpose-built respiratory hardware with proprietary architectural features (AffloVest portable vest design, LUISA's TTV-VAP-AE ventilation mode, SimplyAir's foam-free bi-level construction) plus cloud-based remote monitoring via Löwenstein's Prisma Cloud platform, which gives physicians remote access to patient device data. Movair generates revenue primarily through hardware sales of durable medical equipment to patients and healthcare providers, supplemented by reimbursement support services that facilitate insurance, Medicare, and Medicaid claims. Distribution is exclusively domestic (United States), conducted through physician-prescribed, hospital and clinical channels under FDA regulatory oversight, with all devices requiring a physician order per U.S. federal law.

The go-to-market model is enterprise field sales through healthcare providers and clinical partnerships, with the company maintaining a certified customer repair portal and customer portal for ongoing patient support. The partnership with Löwenstein Medical is the most strategically significant external relationship, providing the ventilation technology underlying LUISA and the Prisma Cloud remote monitoring infrastructure. Leadership consists of founder and CEO Syed Shabbir Hussain Rizvi, with the broader management team not disclosed in available source material.

International Biophysics Corporation firmographics

Firmographics
Name
International Biophysics Corporation
Legal name
International Biophysics Corporation
Website
https://biophysicscorp.com
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
11–50 employees
Short description
International Biophysics Corporation (Movair) is an Austin-based medical device company that designs, sells, and supports FDA-regulated respiratory therapy hardware — the AffloVest, LUISA portable ventilator, and SimplyAir bi-level device — for patients with chronic respiratory conditions, distributed domestically through physician-prescribed clinical channels.
Ownership category
akta.pro rank

International Biophysics Corporation industry classification

Industry
Product category
Respiratory Medical Devices
NAICS
Medical Equipment and Supplies Manufacturing (3391), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)
akta.pro secondary industries
Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG), Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM)

Keywords

  • Respiratory medical devices
  • Home ventilators
  • Bi-level therapy devices
  • Portable ventilators
  • Mechanical insufflation devices

Where International Biophysics Corporation is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

International Biophysics Corporation business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Medical Device Sales: Sale of respiratory medical devices including AffloVest, LUISA ventilator, and SimplyAir Bi-Levels to patients and healthcare providers. Devices require physician prescription and are subject to FDA regulation.
  2. Reimbursement Services: The company provides reimbursement support for SimplyAir and LUISA devices, indicating revenue recovery through healthcare insurance and Medicare/Medicaid channels typical for durable medical equipment.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

International Biophysics Corporation product offering

Product offering

Core offering

International Biophysics Corporation (doing business as Movair) designs, manufactures, and distributes FDA-regulated respiratory medical devices for patients with chronic respiratory conditions. Its product portfolio includes the AffloVest wearable respiratory therapy vest, the LUISA portable home ventilator (FDA EUA-authorized, co-developed with Löwenstein Medical), and the SimplyAir foam-free bi-level positive airway pressure device. The company sells through healthcare provider channels with physician prescription requirements and provides reimbursement support services.

Product overview

International Biophysics Corporation (doing business as Movair) offers a unified portfolio of respiratory care medical devices. The product lineup includes the AffloVest (portable mechanical insufflation-exsufflation therapy vest), LUISA (a portable home ventilator developed with Löwenstein Medical, FDA EUA authorized), and SimplyAir (a FOAM FREE bi-level device). These products work together to provide comprehensive respiratory support across different therapy modalities—from mechanical cough assistance to non-invasive ventilation—enabling patients with chronic respiratory conditions to receive targeted treatment at home.

Differentiator

Problem solved

Functional benefit

Products and services

  • AffloVest

Companies that use International Biophysics Corporation

Customer profile

Segments1 record

Ideal customer profiles2 records

International Biophysics Corporation technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

International Biophysics Corporation partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Löwenstein MedicalcoreStrategic or Co-development PartnerLöwenstein Medical co-developed the LUISA portable home ventilator with Movair. The LUISA represents a strategic collaboration combining Movair's respiratory therapy expertise with Löwenstein Medical's ventilation technology. The device has received FDA emergency use authorization.

Scale indicators1 record

Recent moves7 records

Expansion highlights4 records

International Biophysics Corporation competitors and assessment

Company assessment

Direct peers

  • ResMed: Global leader in CPAP, BiPAP, and home ventilation devices serving patients with sleep apnea and chronic respiratory conditions. Directly comparable to Movair's LUISA home ventilator and SimplyAir Bi-level offerings, with overlapping physician and DME channel.
  • Hamilton Medical: Swiss manufacturer of mechanical ventilators for ICU, transport, and home use. Comparable to Movair in ventilation technology focus, with complementary ICU/home portfolio that may overlap with Movair's LUISA home ventilator.
  • Philips Respironics: Major manufacturer of CPAP, BiPAP, and home/hospital ventilators. Competes head-to-head with Movair's home ventilator and Bi-level portfolio across US hospital and DME channels.
  • Löwenstein Medical: German respiratory and ventilation device manufacturer and Movair's strategic co-development partner on LUISA. Operates in overlapping therapeutic categories including home ventilation and NIV, and is both a partner and direct competitive peer.
  • Drive DeVilbiss Healthcare: US-based manufacturer and distributor of respiratory DME including CPAP, BiPAP, and oxygen therapy devices. Comparable channel strategy through DME providers and overlapping product categories with Movair.
  • React Health (formerly Ventec Life Systems + 3B Medical): US respiratory device company offering home and portable ventilators (VOCSN) plus sleep therapy devices. Directly comparable to Movair's multi-modality home respiratory portfolio and channel strategy.
  • Breas Medical: Specialist in home mechanical ventilators and Bi-level PAP devices, headquartered in Europe with US distribution. Closely comparable to Movair's LUISA and SimplyAir product positioning for chronic respiratory patients.

Emerging players

  • BMC Medical: China-based manufacturer of CPAP, BiPAP, and respiratory care devices expanding internationally. Competes in the same BiPAP and home ventilation categories as Movair's SimplyAir and LUISA, particularly in non-US markets.

Regional players

  • Inogen: US-based manufacturer of portable oxygen concentrators for chronic respiratory patients. Comparable home-channel respiratory therapy model but oxygen-focused; serves overlapping chronic respiratory patient segments.

Broad incumbents

  • Fisher & Paykel Healthcare: New Zealand-based manufacturer of respiratory care products including humidification, NIV masks, and circuits. Adjacent to Movair's NIV and home respiratory therapy portfolio through hospital and home care channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

International Biophysics Corporation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

International Biophysics Corporation leadership team

Management profile

Number of profiles

Profiles1 record

International Biophysics Corporation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

International Biophysics Corporation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Biophysics Corporation

What does International Biophysics Corporation do?

International Biophysics Corporation (doing business as Movair) designs, manufactures, and distributes FDA-regulated respiratory medical devices for patients with chronic respiratory conditions. Its product portfolio includes the AffloVest wearable respiratory therapy vest, the LUISA portable home ventilator (FDA EUA-authorized, co-developed with Löwenstein Medical), and the SimplyAir foam-free bi-level positive airway pressure device. The company sells through healthcare provider channels with physician prescription requirements and provides reimbursement support services.

Is International Biophysics Corporation a public or private company?

International Biophysics Corporation is a private company. It is classified as unknown and is currently operating.

When was International Biophysics Corporation founded?

International Biophysics Corporation was founded in 1994. It employs 11 to 50 people.

Where is International Biophysics Corporation based?

International Biophysics Corporation is headquartered in Austin, United States, in the North America region.

How does International Biophysics Corporation make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are reimbursement Services.

Who are International Biophysics Corporation's main competitors?

Direct peers on record are ResMed, Hamilton Medical, Philips Respironics, Löwenstein Medical, Drive DeVilbiss Healthcare, React Health (formerly Ventec Life Systems + 3B Medical) and Breas Medical. BMC Medical is listed as an emerging player. Inogen is listed as a regional player. Fisher & Paykel Healthcare is listed as a broad incumbent.

Does International Biophysics Corporation have an API?

No public API is recorded for International Biophysics Corporation.

What industry is International Biophysics Corporation in?

International Biophysics Corporation's product category is Respiratory Medical Devices. Its primary akta.pro industry code is HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home), with a secondary code of HLAHAGAG, Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters). Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireTactile Medical Announces Acquisition of AffloVest®Tactile Medical acquired the assets of AffloVest, a portable respiratory therapy device, from International Biophysics Corporation. The deal is financed with cash and $55 million in borrowings, with AffloVest expected to contribute $5-5.5 million in revenue in 2021. The acquisition aligns with Tactile Medical's growth and margin goals.GlobeNewswireTactile Medical Announces Acquisition of AffloVest®Tactile Systems Technology, Inc. announced the acquisition of the AffloVest respiratory therapy business assets from International Biophysics Corporation on September 8, 2021. The transaction, financed through cash and $55 million in borrowings, is expected to expand Tactile Medical's addressable market in the U.S. by approximately $5 billion and contribute to its revenue growth goals.TactilemedicalTactile Medical Announces Acquisition of AffloVest®Tactile Systems Technology, Inc. announced the acquisition of the AffloVest respiratory therapy business assets from International Biophysics Corporation on September 8, 2021. The transaction, financed through cash and $55 million in borrowings, is expected to add a $5 billion annual addressable market opportunity in the U.S. and contribute approximately $5.0 million to $5.5 million in revenue by the end of 2021.PR NewswireLandmark Pulmonary Clinical Study Published in Respiratory TherapyInternational Biophysics Corporation announced the publication of a clinical study in Respiratory Therapy journal evaluating High Frequency Chest Wall Oscillation (HFCWO) vests, with 32 healthy subjects tested between February and March 2018. The study found that compressor-based HFCWO vests caused significant decreases in lung function parameters (FVC, FEV1, FEF25%-75%) from baseline during use, and critically, the findings do not support the long-held belief that HFCWO vest-induced airflow bias is an operating principle of the therapy. The company's AffloVest mechanical oscillator-based device showed a smaller decline in lung function compared to compressor-based competitors, with the compressor group's FEF25-75% decrease being three times greater than that of the AffloVest.PR NewswireInternational Biophysics is Awarded New Patents for the AffloVest® HFCWO Airway Clearance VestInternational Biophysics received two new patents in February and March 2018 for its AffloVest airway clearance technology. The patents cover a self-contained portable oscillating motor array system designed to treat respiratory diseases such as cystic fibrosis. This development reaffirms the company's position in the mechanical oscillation therapy market.PR Newswire50 AffloVests in 50 States, the Colton Underwood Legacy Foundation and International Biophysics partner to help Cystic Fibrosis patientsThe Colton Underwood Legacy Foundation and International Biophysics Corporation have partnered to donate 50 AffloVest devices to Cystic Fibrosis patients across all 50 U.S. states starting in January 2018. This initiative aims to provide next-generation airway clearance therapy to recipients nominated by the foundation.